![Neil Gallagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Gallagher
Directeur/Membre du Conseil chez
FOGHORN THERAPEUTICS INC.
Fortune : - $ au 31/05/2026
Profil
Neil Gallagher is currently an Independent Director at Foghorn Therapeutics, Inc. since 2025.
Formerly, Dr. Gallagher was Director-Clinical Development at Astex Therapeutics Ltd., Independent Director at Zymeworks, Inc. from 2024 to 2025, President and Head of Research & Development at Syndax Pharmaceuticals, Inc. from 2023 to 2025, Chief Medical Officer and Head of Development at AbbVie, Inc. from 2020 to 2023, and Head of Development, Oncology & Inflammation at Amgen, Inc. from 2016 to 2017.
Education includes doctorates from the University of Birmingham and Trinity College Dublin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Neil Gallagher
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/05/2025 |
Anciens postes connus de Neil Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
| ZYMEWORKS INC. | Directeur/Membre du Conseil | 06/11/2025 |
| SYNDAX PHARMACEUTICALS, INC. | President | 12/05/2025 |
| ABBVIE INC. | Directeur Technique/Scientifique/R&D | 01/04/2023 |
| AMGEN INC. | Corporate Officer/Principal | 01/10/2017 |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Corporate Officer/Principal | - |
Formation de Neil Gallagher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
